In summary, we present a novel “double hit” high-grade B-cell lymphoma cell line, designated DH-My6, with concurrent MYC/IGH and BCL6/IGH rearrangements. This evidence concerns the gene BCL6 and B-cell non-Hodgkin lymphoma.